Literature DB >> 3890782

Surgical management of symptomatic pulmonary aspergilloma.

J W Battaglini, G F Murray, B A Keagy, P J Starek, B R Wilcox.   

Abstract

Pulmonary aspergilloma is a potentially life-threatening disease resulting from the colonization of lung cavities by the ubiquitous fungus Aspergillus fumigatus. Complex aspergilloma, characterized by thick-walled cavities with surrounding parenchymal inflammation, is a risk factor for increased morbidity and mortality. Fifteen patients with symptomatic aspergilloma underwent major thoracic procedures at North Carolina Memorial Hospital between January 1, 1972, and December 31, 1983. Twelve of the patients had hemoptysis; in 7 it was recurrent and in 5, life threatening. Tuberculosis and sarcoidosis were the most common underlying causes of lung disease, and more than half of the patients had other coexistent serious medical illness. Eleven of the 15 patients were seen with complex aspergilloma; all of the 4 major complications and the 2 deaths occurred in these patients. Bronchopleural fistula with persistent air space was the most common serious complication, and required thoracoplasty in 3 patients. Nine patients, including 5 with complex aspergilloma, had no postoperative complications, and there were no recurrent symptoms in any of the 13 operative survivors over a mean follow-up of five years. It is concluded that aggressive pulmonary resection can provide effective long-term palliation in critically ill patients with symptomatic pulmonary aspergilloma.

Entities:  

Mesh:

Year:  1985        PMID: 3890782     DOI: 10.1016/s0003-4975(10)61986-8

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  12 in total

1.  Surgical management of pulmonary aspergilloma. Role of single-stage cavernostomy with muscle transposition.

Authors:  N Ono; K Sato; H Yokomise; K Tamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-01

2.  Is video-assisted thoracic surgery a versatile treatment for both simple and complex pulmonary aspergilloma?

Authors:  Ping Yuan; Zhitian Wang; Feichao Bao; Yunhai Yang; Jian Hu
Journal:  J Thorac Dis       Date:  2014-02       Impact factor: 2.895

3.  Outcomes after pneumonectomy for benign disease: the impact of urgent resection.

Authors:  Jacob Klapper; Sameer Hirji; Matthew G Hartwig; Thomas A D'Amico; David H Harpole; Mark W Onaitis; Mark F Berry
Journal:  J Am Coll Surg       Date:  2014-04-08       Impact factor: 6.113

4.  Indications and outcome of surgery for pulmonary aspergilloma.

Authors:  R el Oakley; M Petrou; P Goldstraw
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

5.  Surgical treatment for pulmonary aspergilloma: a 28 year experience.

Authors:  J C Chen; Y L Chang; S P Luh; J M Lee; Y C Lee
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

6.  Limited thoracoplasty in the management of complicated pulmonary aspergillomas.

Authors:  M al-Zeerah; K Jeyasingham
Journal:  Thorax       Date:  1989-12       Impact factor: 9.139

7.  Management of post-tuberculous complex aspergilloma of the lung: role of surgical resection.

Authors:  S A al-Majed; M Ashour; F A el-Kassimi; I Joharjy; A al-Wazzan; M S al-Hajjaj; R Vijay
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

8.  Surgical treatment for pulmonary aspergilloma: a 35-year experience in the Chinese population.

Authors:  Qian-Kun Chen; Ge-Ning Jiang; Jia-An Ding
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-04-11

9.  Risk factors of severe hemoptysis in patients with fungus ball.

Authors:  Tae Hoon Kim; Hyun Jung Koo; Chae-Man Lim; Sang-Bum Hong; Jin Won Huh; Kyung Wook Jo; Tae Sun Shim; Woo Sung Kim; Younsuck Koh
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

10.  Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence--a National Centre's experience.

Authors:  Shakil Farid; Shaza Mohamed; Mohan Devbhandari; Matthew Kneale; Malcolm Richardson; Sing Y Soon; Mark T Jones; Piotr Krysiak; Rajesh Shah; David W Denning; Kandadai Rammohan
Journal:  J Cardiothorac Surg       Date:  2013-08-05       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.